Dow Up0.00% Nasdaq Up0.09%

Jazz Pharmaceuticals Public Limited Company (JAZZ)

-NasdaqGS
177.09 Up 0.44(0.25%) Nov 28, 1:00PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 306,584   291,230   246,919   235,774  
Cost of Revenue26,994  30,692  30,924  25,643  
Gross Profit 279,590   260,538   215,995   210,131  
Operating Expenses
Research Development22,423  20,090  18,109  18,797  
Selling General and Administrative93,501  100,556  106,363  81,299  
Non Recurring75,000  32,806  127,000  (4,988)
Others30,630  32,795  31,182  20,524  
Total Operating Expenses221,554  186,247  282,654  115,632  
Operating Income or Loss 58,036   74,291   (66,659) 94,499  
Income from Continuing Operations
Total Other Income/Expenses Net6,483  74  123  (969)
Earnings Before Interest And Taxes64,519  74,365  (66,536)93,530  
Interest Expense14,530  11,429  10,076  6,173  
Income Before Tax49,989  62,936  (76,612)87,357  
Income Tax Expense24,221  19,350  17,027  32,064  
Minority Interest(2)73  989   -  
Net Income From Continuing Ops25,766  43,659  (92,650)59,042  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 25,766   43,659   (92,650) 55,293  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 25,766   43,659   (92,650) 55,293  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.